Vitaquest International has announced that it has successfully completed the United States Pharmacopoeia (USP) Quality Systems GMP Audit Program for three of its facilities.
Vitaquest International (West Caldwell, NJ) has announced that it has successfully completed the United States Pharmacopoeia (USP) Quality Systems GMP Audit Program for three of its facilities. The company explained that this was a multi-step process that included GMP facility audits, as well as product quality control and manufacturing process evaluation. The certification gives the company’s clients and consumers increased confidence that Vitaquests products are made to the industry’s highest standards.
“This is an incredible milestone for our organization and is a testament to our commitment to top-notch manufacturing systems and processes, reinforcing our position as an industry leader for dietary supplements,” said Patrick Brueggman, president, and chief executive officer of Vitaquest, in a press release. “The successful completion of USP’s comprehensive review process helps demonstrate the high quality of our dietary supplement products and underscores our team’s dedication to providing our clients and consumers with products that meet GMP standards."
Vitaquest has also secured facility certification from NSF, Quality Assurance International, FSSC 22000, and Health Canada, as well as product certifications from NSF, Informed Manufacturer, Orthodox Union, and Halal.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.